BUZZ-Tenon Medical rises on FDA approval of device to treat joint disorder

Reuters
03-25
BUZZ-Tenon Medical rises on FDA approval of device to treat joint disorder

** Shares of medical device maker Tenon Medical TNON.O, RIC rise 91.2% to $1.87 premarket

** US FDA has cleared TNON's device, Catamaran SI Joint Fusion System, to treat sacroiliac (SI) joint disorders, co said on Monday

** The device serves a dual function, acting as a standalone treatment for SI joint disorders and providing support and stabilization during spinal fusion procedures

** SI joint is the connection point between the sacrum, a triangular bone at the base of spine, and the ilium, a part of pelvis

** Stock fell 87.6% in the last 12 month

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10